Clinical Beneficial Effects of Using Crystalloid only in Recipients of Living Donor Liver Transplantation
Abstract
:1. Introduction
2. Method and Patients
3. Results
4. Discussion
5. Conclusions
Author Contributions
Conflicts of Interest
References
- Shih, T.H.; Huang, C.J.; Chen, C.L.; Cheng, K.W.; Wu, S.C.; Yang, S.C.; Juang, S.E.; Lee, Y.E.; Jawan, B.; Wang, C.H. Impact of Early Release of the IVC Clamp from Different IVC Clamping Maneuvers on Changes in Hemodynamic Parameters in Living Donor Liver Transplantation. Ann. Transplant. 2015, 20, 519–525. [Google Scholar] [CrossRef] [PubMed]
- Cleland, S.; Corredor, C.; Ye, J.J.; Srinivas, C.; McCluskey, S.A. Massive haemorrhage in liver transplantation: Consequences, prediction and management. World J. Transplant. 2016, 6, 291–305. [Google Scholar] [CrossRef] [PubMed]
- Jawan, B.; de Villa, V.; Luk, H.N.; Wang, C.S.; Huang, C.J.; Chen, Y.S.; Wang, C.C.; Cheng, Y.F.; Huang, T.L.; Eng, H.L.; et al. Perioperative normovolemic anemia is safe in pediatric living-donor liver transplantation. Transplantation 2004, 77, 1394–1398. [Google Scholar] [CrossRef] [PubMed]
- Yuasa, T.; Niwa, N.; Kimura, S.; Tsuji, H.; Yurugi, K.; Egawa, H.; Tanaka, K.; Asano, H.; Maekawa, T. Intraoperative blood loss during living donor liver transplantation: An analysis of 635 recipients at a single center. Transfusion 2005, 45, 879–884. [Google Scholar] [CrossRef] [PubMed]
- Fogh-Andersen, N.; Bjerrum, P.J.; Siggaard-Andersen, O. Ionic binding, net charge, and Donnan effect of human serum albumin as a function of pH. Clin. Chem. 1993, 39, 48–52. [Google Scholar] [PubMed]
- Klein, H.G. Immunomodulatory aspects of transfusion: A once and future risk? Anesthesiology 1999, 91, 861–865. [Google Scholar] [CrossRef] [PubMed]
- Ramos, H.C.; Todo, S.; Kang, Y.; Felekouras, E.; Doyle, H.R.; Starzl, T.E. Liver transplantation without the use of blood products. Arch. Surg. 1994, 129, 528–532. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yang, S.C.; Chen, C.L.; Wang, C.H.; Huang, C.J.; Cheng, K.W.; Wu, S.C.; Jawan, B. Intraoperative blood and fluid administration differences in primary liver transplantation versus liver retransplantation. Acta Anaesthesiol. Taiwan 2011, 49, 50–53. [Google Scholar] [CrossRef] [PubMed]
- Wu, S.C.; Chen, C.L.; Wang, C.H.; Huang, C.J.; Cheng, K.W.; Shih, T.H.; Yang, J.C.; Jawan, B. Predictive factors associated with re-exploration for hemostasis in living donor liver transplantation. Ann. Transplant. 2012, 17, 64–71. [Google Scholar] [PubMed]
- Jawan, B.; de Villa, V.; Luk, H.N.; Chen, Y.S.; Chiang, Y.C.; Wang, C.C.; Wang, S.H.; Cheng, Y.F.; Huang, T.L.; Eng, H.L. Ionized calcium changes during living-donor liver transplantation in patients with and without administration of blood-bank products. Transpl. Int. 2003, 16, 510–514. [Google Scholar] [CrossRef] [PubMed]
- Liao, H.L.; Chen, C.L.; Wang, C.H.; Huang, C.J.; Cheng, K.W.; Wang, C.C.; Concejero, A.M.; Wang, S.H.; Liu, Y.W.; Jawade, K. The method and accuracy of documentation of intraoperative fluids management in liver transplantation recipients. Ann. Transplant. 2011, 16, 34–38. [Google Scholar] [PubMed]
- Massicotte, L.; Lenis, S.; Thibeault, L.; Sassine, M.P.; Seal, R.F.; Roy, A. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl. 2006, 12, 117–123. [Google Scholar] [CrossRef] [PubMed]
- Immunogentics Center, UCLA. World Transplant Records. Clinical Transplant; Cecka, J.M., Terasaki, P.I., Eds.; Immunogentics Center, UCLA: Los Angeles, CA, USA, 2002; p. 297. [Google Scholar]
- Drop, L.J.; Geffin, G.A.; O’Keefe, D.D.; Newell, J.B.; Jacobs, M.L.; Fowler, B.N.; Daggett, W.M.; Titus, J.S. Relation between ionized calcium concentration and ventricular pump performance in the dog under hemodynamically controlled conditions. Am. J. Cardiol. 1981, 47, 1041–1051. [Google Scholar] [CrossRef]
- Olinger, G.N.; Hottenrott, C.; Mulder, D.G.; Maloney, J.V., Jr.; Miller, J.; Patterson, R.W.; Sullivan, S.F.; Buckberg, G.D. Acute clinical hypocalcemic myocardial depression during rapid blood transfusion and postoperative hemodialysis: A preventable complication. J. Thorac. Cardiovasc. Surg. 1976, 72, 503–511. [Google Scholar] [CrossRef] [PubMed]
- Howland, W.S.; Schweizer, O.; Jascott, D.; Ragasa, J. Factors influencing the ionization of calcium during major surgical procedures. Surg. Gynecol. Obstet. 1976, 143, 895–900. [Google Scholar] [CrossRef] [PubMed]
- Mimouni, A.; Mimouni, F.; Mimouni, C.; Mou, S.; Ho, M. Effects of albumin on ionized calcium in vitro. Pediatr. Emerg. Care 1991, 7, 149–151. [Google Scholar] [CrossRef] [PubMed]
- Gerlach, H.; Slama, K.J.; Bechstein, W.O.; Lohmann, R.; Hintz, G.; Abraham, K.; Neuhaus, P.; Falke, K. Retrospective statistical analysis of coagulation parameters after 250 liver transplantations. Semin. Thromb. Hemost. 1993, 19, 223–232. [Google Scholar] [CrossRef] [PubMed]
- Vivien, B.; Langeron, O.; Morell, E.; Devilliers, C.; Carli, P.A.; Coriat, P.; Riou, B. Early hypocalcemia in severe trauma. Crit. Care Med. 2005, 33, 1946–5192. [Google Scholar] [CrossRef] [PubMed]
- Kost, G.J.; Jammal, M.A.; Ward, R.E.; Safwat, A.M. Monitoring of ionized calcium during human hepatic transplantation. Critical values and their relevance to cardiac and hemodynamic management. Am. J. Clin. Pathol. 1986, 86, 61–70. [Google Scholar] [CrossRef] [PubMed]
- Bar-Or, D.; Thomas, G.W.; Bar-Or, R.; Rael, L.T.; Scarborough, K.; Rao, N.; Shimonkevitz, R. Commercial human albumin preparations for clinical use are immunosuppressive in vitro. Crit. Care Med. 2006, 34, 1707–1712. [Google Scholar] [CrossRef] [PubMed]
GI (n = 389) | GII (n = 73) | GIII (n = 15) | p | |
---|---|---|---|---|
Age (Y) | 53.6 ± 7.4 | 52.0 ± 9.8 | 52.5 ± 7.7 | n.s. |
Weight (Kg) | 66.2 ± 11.0 | 69.3 ± 9.1 | 69.8 ± 13.5 | n.s. |
Anesthesia time (h) | 14.1 ± 1.8 | 13.8 ± 1.3 | 13.1 ± 1.0 | n.s. |
Ascites (mL) | 3176 ± 4926 | 289 ± 1191 | 10 ± 28.0 | *# |
Blood loss mixed with ascites (mL) | 5804 ± 8773 | 718 ± 516 | 539 ± 396 | *# |
Red blood cell (mL) | 4350 ± 6230 | 000 | 000 | *# |
FFP (mL) | 1007 ± 1354 | 000 | 000 | *# |
Platelet (mL) | 180.5 ± 301.1 | 000 | 000 | *# |
5% albumin (mL) | 3480 ± 2379 | 1613 ± 780 | 000 | *#+ |
Crystalloids (mL) | 12652 ± 8192 | 9391 ± 9776 | 9580 ± 2257 | *# |
Hemoglobin pre-op (g/dL) | 10.2 ± 1.9 | 13.2 ± 2.0 | 12.7 ± 1.8 | *# |
Hemoglobin end op (g/dL) | 9.1 ± 1.5 | 10.1 ± 1.6 | 11.4 ± 1.8 | *#+ |
Platelet count | 68.3 ± 42.5 | 103.3 ± 54.8 | 54.9 ± 31.9 | #+ |
INR | 1.39 ± 0.5 | 1.11 ± 0.12 | 1.13 ± 1.1 | n.s. |
APTT | 37.8 ± 11.1 | 33.0 ± 6.0 | 31.7 ± 4.4 | n.s. |
Serum albumin | 2.8 ± 0.5 | 3.6 ± 0.6 | 3.5 ± 0.5 | *# |
Ca++ after Induction (mmol/L) | 0.96 ± 0.49 | 0.90 ± 0.2 | 0.99 ± 0.11 | n.s. |
Ca++ dissection (mmol/L) | 0.91 ± 0.18 | 0.88 ± 0.19 | 0.93 ± 0.11 | n.s. |
Ca++ anhepatic (mmol/L) | 0.92 ± 0.2 | 0.93 ± 0.17 | 0.88 ± 0.11 | n.s. |
Ca++ reperfusion (mmol/L) | 1.0 ± 0.21 | 1.07 ± 0.22 | 0.92 ± 0.15 | n.s. |
Ca++ end op (mmol/L) | 1.0 ± 0.21 | 1.04 ± 0.21 | 0.92 ± 0.11 | n.s. |
Calcium Supplementation (mEq) | 52.1 ± 59.2 | 28.0 ± 11.4 | 9.15 ± 6.3 | *#+ |
pH after anesthesia | 7.43 ± 0.5 | 7.43 ± 0.5 | 7.41 ± 0.6 | # |
pH during dissection | 7.36 ± 0.6 | 7.39 ± 0.6 | 7.38 ± 0.6 | # |
pH anhepatic | 7.27 ± 0.2 | 7.35 ± 0.4 | 7.35 ± 0.4 | *# |
pH reperfusion | 7.27 ± 0.6 | 7.30 ± 0.4 | 7.32 ± 0.3 | *# |
pH end op | 7.3 ± 0.7 | 7.32 ± 0.6 | 7.34 ± 0.5 | n.s. |
NaHCO3 (mEq) | 317 ± 333 | 151 ± 9.4 | 113 ± 47.6 | *# |
Ventilation time (h) | 39 ± 73.9 | 13.3 ± 7.7 | 16.5 ± 6.8 | *# |
GI (389) | GII (73) | GIII (15) | p-Value | |
---|---|---|---|---|
One year acute rejection | 20.4% | 38.4% | 14.3% | 0.05 |
One year survival | 94.1% | 98.6% | 100% | 0.82 |
Three year survival | 90.5% | 94.5% | 100% | 0.127 |
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Huang, C.-J.; Cheng, K.-W.; Chen, C.-L.; Wu, S.-C.; Shih, T.-H.; Yang, S.-C.; Juang, S.-E.; Lee, Y.-E.; Huang, C.-E.; Jawan, B.; et al. Clinical Beneficial Effects of Using Crystalloid only in Recipients of Living Donor Liver Transplantation. Int. J. Environ. Res. Public Health 2017, 14, 1418. https://doi.org/10.3390/ijerph14111418
Huang C-J, Cheng K-W, Chen C-L, Wu S-C, Shih T-H, Yang S-C, Juang S-E, Lee Y-E, Huang C-E, Jawan B, et al. Clinical Beneficial Effects of Using Crystalloid only in Recipients of Living Donor Liver Transplantation. International Journal of Environmental Research and Public Health. 2017; 14(11):1418. https://doi.org/10.3390/ijerph14111418
Chicago/Turabian StyleHuang, Chia-Jung, Kwok-Wai Cheng, Chao-Long Chen, Shao-Chun Wu, Tsung-Hsiao Shih, Sheng-Chun Yang, Sin-Ei Juang, Ying-En Lee, Chiu-En Huang, Bruno Jawan, and et al. 2017. "Clinical Beneficial Effects of Using Crystalloid only in Recipients of Living Donor Liver Transplantation" International Journal of Environmental Research and Public Health 14, no. 11: 1418. https://doi.org/10.3390/ijerph14111418